Stay updated on Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    System revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:12:48.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice and NIH Clinical Center operating status banner, and added a Revision: v3.4.2 tag. The core study content and user-facing information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:57:42.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice informs users about potential delays due to a lapse in government funding and notes that the NIH Clinical Center is open, and the revision tag has been updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:23:52.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Additions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T04:11:57.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:45:27.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Location details updated: New York and Washington sites added; related location sections adjusted and the HHS disclosure link removed (revision v3.3.3).
    Difference
    0.3%
    Check dated 2025-12-23T09:55:18.000Z thumbnail image

Stay in the know with updates to Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.